SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001750019-19-000044
Filing Date
2019-08-08
Accepted
2019-08-08 07:57:01
Documents
3
Period of Report
2019-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K 19Q2 TCRR EARNINGS RELEASE tcrr8-k19q2.htm 8-K 27002
2 EXHIBIT 99.1 TCRR 19Q2 EARNINGS RELEASE tcrr19q2earningsrelease.htm EX-99.1 175014
3 LOGO tcr2logohiresa03.jpg GRAPHIC 167882
  Complete submission text file 0001750019-19-000044.txt   419042
Mailing Address 100 BINNEY STREET CAMBRIDGE MA 02142
Business Address 100 BINNEY STREET CAMBRIDGE MA 02142 617-949-5200
TCR2 THERAPEUTICS INC. (Filer) CIK: 0001750019 (see all company filings)

IRS No.: 474152751 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38811 | Film No.: 191007508
SIC: 2836 Biological Products, (No Diagnostic Substances)